This inventor holds 1 USPTO granted patent. Top assignee: Katholieke Universiteit Leuven. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Melanie Reich
Introduction
Melanie Reich is a notable inventor based in Wakkerzeel, Belgium. She has made significant strides in the field of medicinal chemistry, particularly in the development of compounds aimed at treating specific disorders. Her work is characterized by a commitment to addressing complex health issues through innovative solutions.
Latest Patents
Melanie holds a patent for "Heterocycle derivatives for treating TRPM3 mediated disorders." This invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, particularly those selected from pain and inflammatory hypersensitivity. The patent also outlines a method for the prevention or treatment of these disorders, showcasing her dedication to advancing medical science.
Career Highlights
Melanie Reich is affiliated with Katholieke Universiteit Leuven, a prestigious institution known for its research and innovation. Her role at the university allows her to engage in cutting-edge research and collaborate with other experts in her field.
Collaborations
One of her notable collaborators is Patrick Chaltin, with whom she has worked on various projects aimed at enhancing the understanding and treatment of TRPM3 mediated disorders.
Conclusion
Melanie Reich's contributions to the field of medicinal chemistry are commendable, particularly her innovative patent addressing TRPM3 mediated disorders. Her work exemplifies the impact of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile